1339 GMT - - Bayer reported fourth-quarter results that were generally above Barclays's forecasts while 2025 group guidance for sales also came in slightly better at the midpoint. The midpoint of the Ebitda target was marginally above the bank's expectations, though free cash flow guide was set lower than Barclays's views, it says. The U.K. bank expects the focus of the company's earnings call to include the potential impact of tariffs, particularly on crop science, and free cash flow over the next couple of years. The bank had been forecasting free cash flow of 2.6 billion euros or 2025 versus company guidance of 1.5 billion to 2.5 billion euros. Barclays has an equal weight rating and 22 euro price target on the stock. Shares rise 3.1% at 24.25 euros. (dominic.chopping@wsj.com)
(END) Dow Jones Newswires
March 05, 2025 08:39 ET (13:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。